Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Prepaid Assets (2021 - 2026)

TriSalus Life Sciences has reported Prepaid Assets over the past 6 years, most recently at $2.6 million for Q1 2026.

  • For Q1 2026, Prepaid Assets rose 4.47% year-over-year to $2.6 million; the TTM value through Mar 2026 reached $2.6 million, up 4.47%, while the annual FY2025 figure was $2.2 million, 27.88% down from the prior year.
  • Prepaid Assets for Q1 2026 was $2.6 million at TriSalus Life Sciences, up from $2.2 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $4.8 million in Q4 2022 and troughed at $57479.0 in Q2 2023.
  • A 5-year average of $2.1 million and a median of $2.4 million in 2025 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: plummeted 70.86% in 2023 and later soared 5660.36% in 2024.
  • Year by year, Prepaid Assets stood at $4.8 million in 2022, then plummeted by 37.43% to $3.0 million in 2023, then increased by 0.77% to $3.0 million in 2024, then dropped by 27.88% to $2.2 million in 2025, then grew by 19.45% to $2.6 million in 2026.
  • Business Quant data shows Prepaid Assets for TLSI at $2.6 million in Q1 2026, $2.2 million in Q4 2025, and $2.4 million in Q3 2025.